[Cardiovascular risk stratification in general practice]

H Gohlke1, A Schirmer, K-H Theobald

  • 1Klinische Kardiologie II, Herz-Zentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany.

Zeitschrift Fur Kardiologie
|March 17, 2004
PubMed

Insights

The European Society of Cardiology (ESC) risk charts effectively identify high-risk patients for preventive treatment in general practice. This approach supports evidence-based medicine in daily cardiology practice.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Context:

  • Cardiovascular diseases are a leading cause of premature death in Germany.
  • High-risk individuals for cardiovascular events are often undiagnosed in primary care settings.
  • Systematic risk stratification is crucial for cost-effective management and prevention.

Purpose:

  • To evaluate the utility of European Society of Cardiology (ESC) risk charts for identifying high-risk patients in general practice.
  • To assess the feasibility of implementing ESC risk charts in routine clinical practice.
  • To determine the impact of risk stratification on subsequent preventive treatment.

Summary:

  • A "CAD-scoring week" involved 1122 general practitioners evaluating over 27,000 patients aged >50 using ESC risk charts.
  • Prevalence of risk factors included elevated blood pressure, high cholesterol, smoking, and diabetes, with significant differences between sexes.
  • 19.4% of women and 53% of men were newly identified as high-risk (10-year risk >20%).
  • Over 40% of identified high-risk patients received preventive drug therapy (aspirin, lipid-lowering, or ACE inhibitors).

Impact:

  • The ESC risk charts are a valuable tool for identifying patients eligible for preventive treatment in general practice.
  • Physician feedback indicated that over 70% found the charts helpful in patient management.
  • Implementation of these charts promotes evidence-based medicine in preventive cardiology.
  • This systematic approach facilitates early intervention, potentially reducing cardiovascular disease burden.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...